linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Financial Ratios  
Torrent Pharmaceuticals Ltd.
 
BSE Code 500420
ISIN Demat INE685A01028
Book Value 266.87
NSE Code TORNTPHARM
Dividend Yield % 0.80
Market Cap 1350092.70
P/E 61.40
EPS 64.97
Face Value 5  
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)55.78  40.10  31.06  58.58  67.23  
   CEPS(Rs)78.22  62.58  50.93  47.09  51.63  
   DPS(Rs)32.00  28.00  22.00  48.00  35.00  
   Book NAV/Share(Rs)224.32  201.76  190.75  374.94  356.30  
   Tax Rate(%)27.67  29.19  33.33  32.38  16.71  
Margin Ratios          
   Core EBITDA Margin(%)36.14  33.18  31.42  30.60  33.45  
   EBIT Margin(%)28.54  25.49  23.90  24.80  25.95  
   Pre Tax Margin(%)26.38  22.01  20.10  21.36  20.85  
   PAT Margin (%)19.08  15.58  13.40  14.44  17.37  
   Cash Profit Margin (%)26.76  24.32  21.97  23.22  26.68  
Performance Ratios          
   ROA(%)14.97  10.75  8.75  8.66  9.66  
   ROE(%)26.18  20.43  16.43  16.02  20.41  
   ROCE(%)27.82  20.96  18.10  16.94  16.30  
   Asset Turnover(x)0.78  0.69  0.65  0.60  0.56  
   Sales/Fixed Asset(x)0.75  0.69  0.70  0.69  0.66  
   Working Capital/Sales(x)7.23  11.57  15.15  4.55  4.21  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.33  1.46  1.43  1.45  1.51  
   Receivable days69.04  69.19  76.09  82.04  85.05  
   Inventory Days57.67  66.39  79.08  98.61  95.25  
   Payable days137.91  131.32  117.53  136.79  163.65  
Valuation Parameters          
   PER(x)57.98  64.87  49.49  47.73  37.80  
   PCE(x)41.35  41.56  30.19  29.69  24.61  
   Price/Book(x)14.42  12.89  8.06  7.46  7.13  
   Yield(%)0.99  1.08  1.43  1.72  1.38  
   EV/Net Sales(x)11.56  10.70  7.34  7.50  7.34  
   EV/Core EBITDA(x)31.02  30.62  22.16  21.95  20.49  
   EV/EBIT(x)39.64  41.12  30.11  29.72  27.83  
   EV/CE(x)11.04  8.98  5.12  4.54  4.03  
   M Cap / Sales11.31  10.32  6.76  7.02  6.67  
Growth Ratio          
   Net Sales Growth(%)13.47  10.89  14.13  4.52  4.57  
   Core EBITDA Growth(%)21.02  17.02  10.50  -0.22  7.25  
   EBIT Growth(%)27.21  18.40  10.11  0.13  9.89  
   PAT Growth(%)39.13  29.07  6.05  -12.87  21.24  
   EPS Growth(%)39.13  29.07  -46.97  -12.87  21.24  
Financial Stability Ratios          
   Total Debt/Equity(x)0.34  0.49  0.71  0.53  0.73  
   Current Ratio(x)1.46  1.25  1.15  1.62  1.60  
   Quick Ratio(x)0.95  0.73  0.69  0.90  0.88  
   Interest Cover(x)13.23  7.32  6.30  7.21  5.09  
   Total Debt/Mcap(x)0.02  0.04  0.09  0.07  0.10  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.